Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 23

1.

Contingency management for treatment of substance use disorders: a meta-analysis.

Prendergast M, Podus D, Finney J, Greenwell L, Roll J.

Addiction. 2006 Nov;101(11):1546-60. Review.

PMID:
17034434
2.

A meta-analysis of voucher-based reinforcement therapy for substance use disorders.

Lussier JP, Heil SH, Mongeon JA, Badger GJ, Higgins ST.

Addiction. 2006 Feb;101(2):192-203. Review.

PMID:
16445548
3.

[Contingency management in opioid substitution treatment].

Specka M, Böning A, Scherbaum N.

Fortschr Neurol Psychiatr. 2011 Jul;79(7):395-403. doi: 10.1055/s-0029-1245810. Epub 2010 Nov 24. Review. German.

PMID:
21108163
4.

Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation.

Shepherd J, Jones J, Frampton GK, Tanajewski L, Turner D, Price A.

Health Technol Assess. 2008 Jun;12(28):iii-iv, ix-95. Review.

5.

Effectiveness of motivational interviewing interventions for adolescent substance use behavior change: a meta-analytic review.

Jensen CD, Cushing CC, Aylward BS, Craig JT, Sorell DM, Steele RG.

J Consult Clin Psychol. 2011 Aug;79(4):433-40. doi: 10.1037/a0023992. Review.

PMID:
21728400
6.

Oral naltrexone as a treatment for relapse prevention in formerly opioid-dependent drug users: a systematic review and economic evaluation.

Adi Y, Juarez-Garcia A, Wang D, Jowett S, Frew E, Day E, Bayliss S, Roberts T, Burls A.

Health Technol Assess. 2007 Feb;11(6):iii-iv, 1-85. Review.

8.
9.

Update on behavioral treatments for substance abuse.

Childress A, Ehrman R, McLellan A, O'Brien C.

NIDA Res Monogr. 1988;90:183-92. Review.

PMID:
3151925
10.

Contingency management. Incentives for sobriety.

Higgins ST, Petry NM.

Alcohol Res Health. 1999;23(2):122-7. Review.

PMID:
10890806
11.

Motivation and Contingency Management Treatments for Substance Use Disorders.

Walter KN, Petry NM.

Curr Top Behav Neurosci. 2016;27:569-81. doi: 10.1007/7854_2015_374. Review.

PMID:
25762429
12.
13.

Economic evaluations of contingency management in illicit drug misuse programmes: A systematic review.

Shearer J, Tie H, Byford S.

Drug Alcohol Rev. 2015 May;34(3):289-98. doi: 10.1111/dar.12240. Epub 2015 Feb 8. Review.

PMID:
25659953
14.

Salient variables for treatment research of adolescent alcohol and other substance use disorders.

Bukstein OG, Winters K.

Addiction. 2004 Nov;99 Suppl 2:23-37. Review.

PMID:
15488103
15.

Contingency management approaches for adolescent substance use disorders.

Stanger C, Budney AJ.

Child Adolesc Psychiatr Clin N Am. 2010 Jul;19(3):547-62. doi: 10.1016/j.chc.2010.03.007. Review.

16.

Neurobehavioral treatment for cocaine dependency: a preliminary evaluation.

Rawson RA, Obert JL, McCann MJ, Ling W.

NIDA Res Monogr. 1993;135:92-115. Review.

PMID:
8289906
17.

The clinical effectiveness and cost-effectiveness of cardiac resynchronisation (biventricular pacing) for heart failure: systematic review and economic model.

Fox M, Mealing S, Anderson R, Dean J, Stein K, Price A, Taylor RS.

Health Technol Assess. 2007 Nov;11(47):iii-iv, ix-248. Review.

18.

Contingency management for substance use disorders in Spain: Implications for research and practice.

Secades-Villa R, García-Rodríguez O, Fernández-Hermida JR.

Prev Med. 2015 Nov;80:82-8. doi: 10.1016/j.ypmed.2015.07.001. Epub 2015 Jul 9. Review.

PMID:
26164071
19.

Advances in Research on Contingency Management for Adolescent Substance Use.

Stanger C, Lansing AH, Budney AJ.

Child Adolesc Psychiatr Clin N Am. 2016 Oct;25(4):645-59. doi: 10.1016/j.chc.2016.05.002. Review.

20.

Treatment of cocaine dependence through the principles of behavior analysis and behavioral pharmacology.

Higgins ST, Budney AJ.

NIDA Res Monogr. 1993;137:97-121. Review. No abstract available.

PMID:
8289930

Supplemental Content

Support Center